Cargando…
Ainsliadimer A selectively inhibits IKKα/β by covalently binding a conserved cysteine
Aberrant activation of NF-κB is associated with the development of cancer and autoimmune and inflammatory diseases. IKKs are well recognized as key regulators in the NF-κB pathway and therefore represent attractive targets for intervention with small molecule inhibitors. Herein, we report that a com...
Autores principales: | Dong, Ting, Li, Chao, Wang, Xing, Dian, Longyang, Zhang, Xiuguo, Li, Lin, Chen, She, Cao, Ran, Li, Li, Huang, Niu, He, Sudan, Lei, Xiaoguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389228/ https://www.ncbi.nlm.nih.gov/pubmed/25813672 http://dx.doi.org/10.1038/ncomms7522 |
Ejemplares similares
-
Mutation of cysteine 46 in IKK-beta increases inflammatory responses
por: Li, Ting, et al.
Publicado: (2015) -
Xanthatin inhibits STAT3 and NF‐κB signalling by covalently binding to JAK and IKK kinases
por: Liu, Man, et al.
Publicado: (2019) -
Pironetin reacts covalently with cysteine-316 of α-tubulin to destabilize microtubule
por: Yang, Jianhong, et al.
Publicado: (2016) -
Isoliquiritigenin suppresses human T Lymphocyte activation via covalently binding cysteine 46 of IκB kinase
por: Yan, Fenggen, et al.
Publicado: (2016) -
IKKα contributes to UVB-induced VEGF expression by regulating AP-1 transactivation
por: Dong, Wen, et al.
Publicado: (2012)